Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors.

The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors. Curr Opin Oncol. 2014 Jul; 26(4):415-21.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.